Usefulness of competitive inhibitors of protein binding for improving the pharmacokinetics of 186Re-MAG3-conjugated bisphosphonate (186Re-MAG3-HBP), an agent for treatment of painful bone metastases.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples